Partager
Ecouter
Actualité

Social amoebae as a new chassis for drug production

  • Pharmacie,
  • Santé-Sciences-Technologie,
amibe
amibe
Date(s)

du 21 février 2022 au 21 février 2024

Lieu(x)

Site Grandmont

EA2106 BBV - Biomolécules et Biotechnologies végétales

Social amoebae as a new chassis for drug production : our new spotlight published in Trends in Biotechnology

"Social amoebae as a new chassis for drug production"  by Vincent Courdavault1*  and Nicolas Papon2*
Trends in Biotechnology 2022 : DOI:https://doi.org/10.1016/j.tibtech.2022.02.002

1Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France
2Univ. Angers, Univ. Brest, GEIHP, IRF, SFR ICAT, F-49000 Angers, France
*corresponding author
 

Abstract

Engineered bacteria and yeasts have progressively emerged in the past decade as convenient cell factories for supplying plant and fungal natural products (NPs). A new study by Reimer et al. provides compelling evidence that the amoeba Dictyostelium discoideum could be also engineered in favor of the production of plant drug precursors.